Selenomethionine treatment in patients with autoimmune thyroiditis: A prospective, quasi-randomised trial

International Journal of Clinical Practice

Volumn 66, Issue 4, 2012, Pages 378-383

  Anastasilakis, Athanasios D ^a   Toulis, K A ^a   Nisianakis, P ^b   Goulis, D G ^c   Kampas, L ^a   Valeri, R M ^d   Oikonomou, D ^a   Tzellos, T G ^c   Delaroudis, S ^a  

^a 424 General Army Hospital   (Greece)

^b Center of Biological Research of Armed Forces (KBIES)   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Department of Cytopathology   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PLACEBO; SELENIUM; SELENOMETHIONINE; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOSAGE SCHEDULE COMPARISON; FEMALE; FREE LIOTHYRONINE INDEX; HASHIMOTO DISEASE; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AUTOANTIBODIES; FEMALE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SELENOMETHIONINE; THYROGLOBULIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859108711     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02879.x     Document Type: Article

References (25)

1. Kohrle J, Jakob F, Contempre B, Dumont JE,. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005; 26: 944-84. (Pubitemid 41770159)
2. Tiran B, Karpf E, Tiran A,. Age dependency of selenium and cadmium content in human liver, kidney, and thyroid. Arch Environ Health 1995; 50: 242-6.
3. Beckett GJ, Arthur JR,. Selenium and endocrine systems. J Endocrinol 2005; 184: 455-65. (Pubitemid 40426009)
4. Behne D, Hilmert H, Scheid S, et al., Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochem Biophys Acta 1988; 966: 12-21.
5. Duntas LH,. Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 2008; 4: 454-60.
6. Pearce EN, Farwell AP, Braverman LE, Thyroiditis. N Engl J Med 2003; 348: 2646-55. (Pubitemid 36741593)
7. Duntas LH, Mantzou E, Koutras DA,. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 2003; 148: 389-93. (Pubitemid 36527409)
8. Gartner R, Gasnier BC,. Selenium in the treatment of autoimmune thyroiditis. BioFactors 2003; 19: 165-70. (Pubitemid 38180454)
9. Gartner R, Gasnier BC, Dietrich JW, et al., Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002; 87: 1687-91. (Pubitemid 34618503)
10. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, et al., Effects of 12 months treatment with l-selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid 2007; 17: 609-12. (Pubitemid 47311547)
11. Turker O, Karapolat I,. There is immunological benefit of selenium treatment in autoimmune thyroiditis. Thyroid 2008; 18: 671-2. (Pubitemid 351918456)
12. Karanikas G, Schuetz M, Kontur S, et al., No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 2008; 18: 7-12. (Pubitemid 351170446)
13. Derumeaux H, Valeix P, Castetbon K, et al., Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur J Endocrinol 2003; 148: 309-15. (Pubitemid 36410716)
14. Negro R, Greco G, Mangieri T, et al., The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007; 92: 1263-8. (Pubitemid 46556396)
15. Contempre B, Duale NL, Dumont JE, et al., Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol (Oxf) 1992; 36: 579-83.
16. Vrca VB, Skreb F, Cepelak I, et al., Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 2004; 341: 55-63. (Pubitemid 38210314)
17. Combs GFJ, Midthune DN, Patterson KY, et al., Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr 2009; 89: 1808-14.
18. Thomson CD, Campbell JM, Miller J, et al., Selenium and iodine supplementation: effect on thyroid function of older New Zealanders. Am J Clin Nutr 2009; 90: 1038-46.
19. Rayman MP, Thompson AJ, Bekaert B, et al., Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 2008; 87: 370-8. (Pubitemid 351226073)
20. Toulis KA, Anastasilakis AD, Tzellos GT, et al., Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis of randomized placebo-controlled studies. Thyroid 2010; 20: 1163-73.
21. Schomburg L,. Treating Hashimoto's thyroiditis with selenium: no risks, just benefits? Thyroid 2011; 21: 563-4.
22. Schomburg L, Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol 2011. doi
23. Pandit AA, Vijay Warde M, Menon PS,. Correlation of number of intrathyroid lymphocytes with antimicrosomal antibody titer in Hashimoto's thyroiditis. Diagn Cytopathol 2003; 28: 63-5. (Pubitemid 36159591)
24. Turker O, Kumanlioglu K, Karapolat I, Dogan I,. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J Endocrinol 2006; 190: 151-6. (Pubitemid 44161070)
25. Nacamulli D, Mian C, Petricca D, et al., Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin Endocrinol (Oxf) 2010; 73: 535-9.